Skip to main content

Table 1 Basic data on microbiological findings within the study population

From: Comparative evaluation of the effect of different growth media on in vitro sensitivity to azithromycin in multi-drug resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients

 

CF patients

 

n

Total

930

P. aeruginosa pos.

292

P. aeruginosa MDR pos.a

49 (=16.8% of P. aeruginosa pos.)

 

MDR P. aeruginosa, b

 

n

%

Agec

 0–10

3

11

 11–20

2

7

 21–30

10

36

 31–40

7

25

 41–50

2

7

 > 51

4

14

Resistance to d

 Colistin

5

17

 Fosfomycin

20

69

 Aztreonam

29

100

 Gentamicin

27

93

 Tobramycin

18

62

 Amikacin

25

86

Carriage status e

 Intermittent

1

4

 Chronic

27

96

  1. a defined as combined resistance to piperacillin/tazobactame, ceftazidime, imipenem, meropenem and ciprofloxacin
  2. b N = 29 isolates from N = 28 patients, i.e. one patient had two morphologically distinct isolates
  3. c median age 27.5 years (range 7 to 70 years); n = 28 patients
  4. d categorized as resistant (i.v. application) if MIC interpreted as intermediate or resistant
  5. e chronic: > 50% P. aeruginosa positive samples within 12 months; intermittent: < 50% P. aeruginosa positive samples within 12 months; negative: > 1 year P. aeruginosa negative